Collegium Pharmaceutical (COLL) Amortizatization of Intangibles (2017 - 2026)

Collegium Pharmaceutical's Amortizatization of Intangibles history runs 10 years deep, the most recent figure standing at $55.5 million for Q1 2026.

• In Q1 2026, Amortizatization of Intangibles rose 17021.3% year-over-year to $55.5 million; the TTM figure through Mar 2026 stood at $1.1 million (down 99.18% YoY), while the FY2025 annual figure was $1.1 million, down 99.35% from the prior year.
• Amortizatization of Intangibles was $55.5 million for Q1 2026 at Collegium Pharmaceutical, up from -$165.3 million in the prior quarter.
• In the past five years, Amortizatization of Intangibles ranged from a high of $55.5 million in Q2 2025 to a low of -$165.3 million in Q4 2025.
• Historically, Amortizatization of Intangibles has averaged $24.4 million across 5 years, with a median of $37.5 million in 2023.
• The sharpest annual moves came in 2025 and 2026: Amortizatization of Intangibles tumbled 398.08% in 2025, then surged 17021.3% in 2026.
• A 5-year view of Amortizatization of Intangibles shows it stood at $42.3 million in 2022, then fell by 18.37% to $34.5 million in 2023, then surged by 60.72% to $55.5 million in 2024, then sank by 398.08% to -$165.3 million in 2025, then surged by 133.55% to $55.5 million in 2026.
• The last three Amortizatization of Intangibles figures came in at $55.5 million (Q1 2026), -$165.3 million (Q4 2025), and $55.5 million (Q3 2025), per Business Quant data.